These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16197363)

  • 21. Safety of meloxicam in patients with aspirin/non-steroidal anti-inflammatory drug-induced urticaria and angioedema.
    Göksel O; Aydin O; Misirligil Z; Demirel YS; Bavbek S
    J Dermatol; 2010 Nov; 37(11):973-9. PubMed ID: 21039786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of cholestyramine on the pharmacokinetics of meloxicam, a new non-steroidal anti-inflammatory drug (NSAID), in man.
    Busch U; Heinzel G; Narjes H
    Eur J Clin Pharmacol; 1995; 48(3-4):269-72. PubMed ID: 7589053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacodynamic and pharmacokinetic aspects of the non-inflammatory non-steroidal agent meloxicam in dogs].
    Poulsen Nautrup B; Hörstermann D
    Dtsch Tierarztl Wochenschr; 1999 Mar; 106(3):94-100. PubMed ID: 10220944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data.
    Layton D; Heeley E; Hughes K; Shakir SA
    Rheumatology (Oxford); 2003 May; 42(5):622-31. PubMed ID: 12709537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.
    Wojtulewski JA; Schattenkirchner M; Barceló P; Le Loët X; Bevis PJ; Bluhmki E; Distel M
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():22-8. PubMed ID: 8630632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and safety of oral administration of meloxicam to foals.
    Raidal SL; Edwards S; Pippia J; Boston R; Noble GK
    J Vet Intern Med; 2013; 27(2):300-7. PubMed ID: 23425143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meloxicam--a safer NSAID?
    Drug Ther Bull; 1998 Aug; 36(8):62-4. PubMed ID: 9876404
    [No Abstract]   [Full Text] [Related]  

  • 28. [The new nonsteroidal anti-inflammatory preparation meloxicam in the treatment of rheumatoid arthritis].
    Grishina EI
    Lik Sprava; 1997; (2):19-25. PubMed ID: 9333474
    [No Abstract]   [Full Text] [Related]  

  • 29. Meloxicam.
    Khalil NY; Aldosari KF
    Profiles Drug Subst Excip Relat Methodol; 2020; 45():159-197. PubMed ID: 32164967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of COX-2-selective meloxicam on the myocardial, vascular and renal risks: a systematic review.
    Asghar W; Jamali F
    Inflammopharmacology; 2015 Feb; 23(1):1-16. PubMed ID: 25515365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ischaemic colitis in a patient taking meloxicam.
    Garcia B; Ramaholimihaso F; Diebold MD; Cadiot G; Thiéfin G
    Lancet; 2001 Mar; 357(9257):690. PubMed ID: 11247558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetic analysis of meloxicam in rheumatoid arthritis patients.
    Meineke I; Türck D
    Br J Clin Pharmacol; 2003 Jan; 55(1):32-8. PubMed ID: 12534638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meloxicam and risk of myocardial infarction: a population-based nested case-control study.
    Dalal D; Dubreuil M; Peloquin C; Neogi T; Zhang Y; Choi H; Felson D
    Rheumatol Int; 2017 Dec; 37(12):2071-2078. PubMed ID: 29030657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The assessment of oral NSAID use in patients with rheumatoid arthritis in Hungary--a cross sectional non interventional study].
    Inotai A; Rojkovich B; Mészáros A
    Acta Pharm Hung; 2010; 80(1):47-54. PubMed ID: 20443365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous meloxicam suspension pharmacokinetics in mice and dose considerations for postoperative analgesia.
    Chen PH; Boyd KL; Fickle EK; Locuson CW
    J Vet Pharmacol Ther; 2016 Aug; 39(4):356-62. PubMed ID: 26896236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single and multiple-dose pharmacokinetics of meloxicam after oral administration to the rabbit (Oryctolagus cuniculus).
    Carpenter JW; Pollock CG; Koch DE; Hunter RP
    J Zoo Wildl Med; 2009 Dec; 40(4):601-6. PubMed ID: 20063804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance to COX-2 inhibitors in children with hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Corzo JL; Zambonino MA; Muñoz C; Mayorga C; Requena G; Urda A; Gallego C; Blanca M; Torres MJ
    Br J Dermatol; 2014 Mar; 170(3):725-9. PubMed ID: 24116718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2.
    Engelhardt G
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():4-12. PubMed ID: 8630636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of inflammation on kidney function and pharmacokinetics of COX-2 selective nonsteroidal anti-inflammatory drugs rofecoxib and meloxicam.
    Harirforoosh S; Jamali F
    J Appl Toxicol; 2008 Oct; 28(7):829-38. PubMed ID: 18344196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and tolerability of meloxicam after i.m. administration.
    Narjes H; Türck D; Busch U; Heinzel G; Nehmiz G
    Br J Clin Pharmacol; 1996 Feb; 41(2):135-9. PubMed ID: 8838440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.